Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/29/1986 | EP0199675A1 Heterocyclic penem compounds |
10/29/1986 | EP0199641A1 Triazole derivatives, process for their preparation and pharmaceutical compositions containing them |
10/29/1986 | EP0199636A1 Benzonaphthalenic derivatives, process for their preparation and their use in pharmacy and cosmetics |
10/29/1986 | EP0199630A1 Substituted azetidinones, pharmaceutical compositions containing them, and their use for the manufacture of anti-inflammatory and antidegenerative medicaments |
10/29/1986 | EP0199591A2 Valiolamine derivatives and production thereof |
10/29/1986 | EP0199543A2 Heterocyclic amide derivatives |
10/29/1986 | EP0199524A2 Platinum tramine antitumor agents |
10/29/1986 | EP0199490A1 Penem derivatives |
10/29/1986 | EP0199451A2 Therapeutic nucleosides |
10/29/1986 | EP0199446A1 Penem compounds, production and use thereof |
10/29/1986 | EP0199400A2 Substituted N-[(4-piperidinyl)alkyl] bicyclic condensed ozazol- and thiazolamines |
10/29/1986 | EP0199393A1 Indene and naphthalene derivatives |
10/29/1986 | EP0199379A2 Pharmacologically active tripeptides and process for their synthesis |
10/29/1986 | EP0199324A2 New 2,5-diaryl tetryhydrofurans and analogs thereof as paf antagonists |
10/29/1986 | EP0199323A2 4-Substituted aminoalkylidene-3-aryl-5(4H) isoxazolines, process for their preparation, medicaments containing them and their use |
10/29/1986 | EP0199291A1 Use of L-ornithine for the preparation of agents for the selective inhibition of T-cell mediated immune reactions |
10/29/1986 | EP0199262A2 Fluorinated benzyl triazole compounds |
10/29/1986 | EP0199247A2 Cytostatic active medicine containing glycidyl amines |
10/29/1986 | EP0199238A1 1,4-Dihydropyridine derivatives, process for their preparation and their use in medicaments |
10/29/1986 | EP0199235A2 Phenylalkyl-2,3-dihydrobenzofurans and analogs useful as anti-inflammatory agents |
10/29/1986 | EP0199170A1 Composition and method for providing cytoprotection of the gastric mucosa in a mammal receiving aspirin |
10/29/1986 | EP0199153A2 Lipoxygenase inhibiting compounds |
10/29/1986 | EP0199152A2 Lipoxygenase inhibiting compounds |
10/29/1986 | EP0199151A2 Lipoxygenase inhibiting compounds |
10/29/1986 | EP0199127A1 5-(6-imidazo[1,2-a]pyridyl) pyridine derivative |
10/29/1986 | EP0199117A2 New therapeutical use of phosphocreatine |
10/29/1986 | EP0199103A2 Process for preventing or reversing cataract formation using protein modification reagents |
10/29/1986 | EP0199096A1 Nitro substituted heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them |
10/29/1986 | EP0199047A2 Iodopropargyl ethers, process for their preparation and their use |
10/29/1986 | EP0199033A2 Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form, and their pharmaceutical use |
10/29/1986 | EP0198965A1 Benzo-pyrones as a treatment for exudative or disciform maculopathy |
10/29/1986 | EP0198919A1 Pharmaceutical preparations. |
10/29/1986 | EP0198901A1 Method for preparing 1alpha-hydroxyvitamin d compounds. |
10/29/1986 | EP0198829A1 9-halogen-prostaglandine derivatives, preparation process and utilization thereof as drugs. |
10/29/1986 | EP0053175B1 Use of d-fenfluramine for the manufacture of a medicament for modifying feeding behavior |
10/29/1986 | CN86103619A Process for preparing 7-substituted bicyclic pyrazolidinones |
10/29/1986 | CN86102877A Process for the preparation of bicyclic phrazolidinones |
10/29/1986 | CN86100228A Process for the preparation of polycyclic salts |
10/29/1986 | CN85109666A Process for the preparation of pharmaceutically active compound |
10/29/1986 | CN85106465A Process for preparing pharmaceuticals-formulation |
10/29/1986 | CN85102147A Process for preparation of 11 beta-arylestradienes and their use |
10/29/1986 | CN85101572A Process for the preparation of 6-(substituted) methylenepenicillanic, 6-(substituted) hydroxymethylpenicillanic acid and derivatives thereof |
10/28/1986 | US4620037 Sequenced surfactant oligomers, process for preparing the same and compositions containing the same |
10/28/1986 | US4620015 Sodium hydride as condensing agent |
10/28/1986 | US4620008 Gastric acid secretion inhibitor intermediates |
10/28/1986 | US4620005 1-isopropyl-4[(4-tetrahydro-1-naphthoyloxy phenyl)(alkylene)-carbonyl(oxymethlcarbonyl)]piperazines having chymotrypsin-inhibitory activity |
10/28/1986 | US4619994 Benzeneazo polynuclear aromatic or heteroaromatic amidine compounds containing amidine substituents |
10/28/1986 | US4619944 Antihypertensive compounds |
10/28/1986 | US4619942 Inhibition of Respiratory Syncytial virus-induced cell fusion by amidino compounds |
10/28/1986 | US4619936 Orally administering nalorphine or a salt thereof |
10/28/1986 | US4619935 Stable oncolytic formulations |
10/28/1986 | US4619934 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
10/28/1986 | US4619931 [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
10/28/1986 | US4619930 Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use |
10/28/1986 | US4619929 Phenylpiperazine derivatives of hetarylphenols and hetarylanilines, their preparation, and therapeutic agents containing these compounds |
10/28/1986 | US4619928 Morpholine-oxazole deravitives |
10/28/1986 | US4619927 Novel nitropyrazinyl- and nitropyridinyl- substituted piperazin-3-one and hexahydro-1H-1,4-diazepin-5-one compounds useful as adjuncts to radiation therapy |
10/28/1986 | US4619926 Antiinflammatory, analgesic agents |
10/28/1986 | US4619925 3-Propenyl cephalosporin derivatives |
10/28/1986 | US4619923 Metal protoporphyrins in the control of tryptophan metabolism |
10/28/1986 | US4619922 6α, 16α-dimethyl corticoids |
10/28/1986 | US4619921 Antiinflammatory agents |
10/28/1986 | US4619919 Treatment of hypertension |
10/28/1986 | US4619915 Antiinfection agents |
10/28/1986 | US4619913 Treatments employing drug-containing matrices for introduction into cellular lesion areas |
10/28/1986 | US4619829 Utilization of a single vitamin or a combination of various vitamins |
10/28/1986 | US4619826 Crosslinked and uncrosslinked addition polymers |
10/28/1986 | US4619787 Beta lactams |
10/28/1986 | US4619786 Preparation of 6-α-bromo- and/or 6,6-dibromo-penicillanic acid-1,1-dioxides |
10/28/1986 | US4619785 Reacting ampicillin with acetoacetic acid derivative, halo-diethyl carbonate, hydrolysis |
10/28/1986 | CA1213397A1 Weight control with alkyl styrene polymers |
10/28/1986 | CA1213284A1 Phosphoric acid diesters or their salts and process for producing the same |
10/28/1986 | CA1213280A1 PROCESS FOR PREPARING NEW 4-(1H-INDOL-3-YL) .alpha.-METHYL PIPERIDINE-1-ETHANOL DERIVATIVES AND THE SALTS THEROF |
10/28/1986 | CA1213279A1 Thiomethylpyridine derivatives, process for the production thereof and medicaments containing them |
10/28/1986 | CA1213278A1 3-azinomethyl rifamycins |
10/28/1986 | CA1213271A1 Androstene-17-dithioketals |
10/28/1986 | CA1213270A1 Antiinflammatory 17, 17-bis(substituted thio) androstenes |
10/28/1986 | CA1213220A1 Base salts of piroxicam deposited on a pharmaceutically-acceptable carrier |
10/28/1986 | CA1213219A1 Pharmaceutical composition for the treatment of diabetes |
10/28/1986 | CA1213218A1 Long-acting formulation of cefaclor |
10/28/1986 | CA1213217A1 Stabilisation of unstable drugs or food supplements |
10/28/1986 | CA1213198A1 Diagnostic activated partial thromboplastin reagent |
10/23/1986 | WO1986006078A1 Skin treatment agents |
10/23/1986 | WO1986006069A1 Thiazolidinedione derivatives, process for their preparation and medicinal composition containing same |
10/23/1986 | WO1986006064A1 Naphthalenic derivatives with retinoid activity, preparation process thereof and medicinal and cosmetic compositions containing them |
10/23/1986 | WO1986005988A1 Nasal compositions containing vitamin b12 |
10/23/1986 | WO1986005987A1 Aerosol compositions for nasal delivery of vitamin b12 |
10/23/1986 | WO1986005986A1 Process for preparing carcinostatic substance complex |
10/23/1986 | WO1986005984A1 Hyaluronic acid preparation to be used for treating inflammations of skeletal joints |
10/23/1986 | WO1986005983A1 N-alkyl and n-benzyl adriamycin derivatives |
10/23/1986 | WO1986005981A1 Treatment of non-ulcer dyspepsia with bismuth salts |
10/23/1986 | WO1986005980A1 Method for eliminating or reducing the desire for smoking |
10/23/1986 | WO1986005979A1 Method for treating the effects of alcohol |
10/23/1986 | WO1986005978A1 Method for treating drug addiction |
10/23/1986 | WO1986005977A1 Steroidal liposomes |
10/22/1986 | EP0198762A1 Dibenzo[b,e]oxepine-acetic-acid derivatives, their preparation, and pharmaceutical preparations containing them |
10/22/1986 | EP0198689A2 Pseudopterosin and synthetic derivatives thereof |
10/22/1986 | EP0198686A2 Anticonvulsant dioxolane methane sulfamates |
10/22/1986 | EP0198678A2 A process for preparing substituted quinoline-3-carboxylic acids |
10/22/1986 | EP0198633A2 Pyridine derivatives |